Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A first-in-human, randomized, placebo-controlled, dose escalation Phase 1 clinical trial of AT-001 in patients with Type 2 Diabetes

Trial Profile

A first-in-human, randomized, placebo-controlled, dose escalation Phase 1 clinical trial of AT-001 in patients with Type 2 Diabetes

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Sep 2018

At a glance

  • Drugs AT 001 (Primary)
  • Indications Diabetic cardiomyopathy; Heart failure; Myocardial infarction; Peripheral nervous system diseases
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 14 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top